These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30385862)

  • 1. Impact of Cardiovascular Magnetic Resonance Imaging on Identifying the Etiology of Cardiomyopathy in Patients Undergoing Cardiac Transplantation.
    Lin LQ; Kazmirczak F; Chen KA; Okasha O; Nijjar PS; Martin CM; Akçakaya M; Farzaneh-Far A; Shenoy C
    Sci Rep; 2018 Nov; 8(1):16212. PubMed ID: 30385862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics, Treatments, and Outcomes of Hospitalized Heart Failure Patients Stratified by Etiologies of Cardiomyopathy.
    Shore S; Grau-Sepulveda MV; Bhatt DL; Heidenreich PA; Eapen ZJ; Hernandez AF; Yancy CW; Fonarow GC
    JACC Heart Fail; 2015 Nov; 3(11):906-16. PubMed ID: 26454848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
    Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M
    Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine versus selective cardiac magnetic resonance in non-ischemic heart failure - OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B).
    Paterson I; Wells GA; Ezekowitz JA; White JA; Friedrich MG; Mielniczuk LM; O'Meara E; Chow B; DeKemp RA; Klein R; Dennie C; Dick A; Coyle D; Dwivedi G; Rajda M; Wright GA; Laine M; Hanninen H; Larose E; Connelly KA; Leong-Poi H; Howarth AG; Davies RA; Duchesne L; Yla-Herttuala S; Saraste A; Farand P; Garrard L; Tardif JC; Arnold M; Knuuti J; Beanlands R; Chan KL
    Trials; 2013 Oct; 14():332. PubMed ID: 24119686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed enhancement magnetic resonance imaging is a significant prognostic factor in patients with non-ischemic cardiomyopathy.
    Cho JR; Park S; Choi BW; Kang SM; Ha JW; Chung N; Choe KO; Cho SY; Rim SJ
    Circ J; 2010 Mar; 74(3):476-83. PubMed ID: 20118568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missed Opportunities in Identifying Cardiomyopathy Aetiology Prior to Advanced Heart Failure Therapy.
    Aiad N; Elnabawai YA; Li B; Narula N; Gidea C; Katz SD; Rao SD; Reyentovich A; Saraon T; Smith D; Moazami N; Pan S
    Heart Lung Circ; 2022 Jun; 31(6):815-821. PubMed ID: 35165053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and nonischemic cardiomyopathy.
    Voskoboinik A; Wong MCG; Elliott JK; Costello BT; Prabhu S; Mariani JA; Kalman JM; Kistler PM; Taylor AJ; Morton JB
    Pacing Clin Electrophysiol; 2018 Sep; 41(9):1109-1115. PubMed ID: 29931686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discrepancies between clinical and histopathological diagnoses of cardiomyopathies in patients with stage D heart failure undergoing heart transplantation.
    Lertsuttimetta T; Tumkosit M; Kaveevorayan P; Chantranuwatana P; Theerasuwipakorn N; Chattranukulchai P; Puwanant S
    PLoS One; 2022; 17(6):e0269019. PubMed ID: 35648762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cardiac MR in new-onset heart failure.
    Kim YJ; Kim RJ
    Curr Cardiol Rep; 2011 Jun; 13(3):185-93. PubMed ID: 21399925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging.
    Mekinian A; Lions C; Leleu X; Duhamel A; Lamblin N; Coiteux V; De Groote P; Hatron PY; Facon T; Beregi JP; Hachulla E; Launay D;
    Am J Med; 2010 Sep; 123(9):864-8. PubMed ID: 20800158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between right ventricular T
    Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance.
    Senthilkumar A; Majmudar MD; Shenoy C; Kim HW; Kim RJ
    Heart Fail Clin; 2009 Jul; 5(3):349-67, vi. PubMed ID: 19564013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of combination of cardiac magnetic resonance imaging and high-sensitivity cardiac troponin T assay in diagnosis of inflammatory cardiomyopathy.
    Šramko M; Kubánek M; Tintěra J; Kautznerová D; Weichet J; Malušková J; Franeková J; Kautzner J
    Am J Cardiol; 2013 Jan; 111(2):258-64. PubMed ID: 23102878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis.
    Iles LM; Ellims AH; Llewellyn H; Hare JL; Kaye DM; McLean CA; Taylor AJ
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):14-22. PubMed ID: 25354866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse myocardial fibrosis among healthy pediatric heart transplant recipients: Correlation of histology, cardiovascular magnetic resonance, and clinical phenotype.
    Feingold B; Salgado CM; Reyes-Múgica M; Drant SE; Miller SA; Kennedy M; Kellman P; Schelbert EB; Wong TC
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28574157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology.
    Assomull RG; Shakespeare C; Kalra PR; Lloyd G; Gulati A; Strange J; Bradlow WM; Lyne J; Keegan J; Poole-Wilson P; Cowie MR; Pennell DJ; Prasad SK
    Circulation; 2011 Sep; 124(12):1351-60. PubMed ID: 21900085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging to differentiate between ischemic and nonischemic cardiomyopathy.
    Bax JJ; Poldermans D; Schuijf JD; Scholte AJ; Elhendy A; van der Wall EE
    Heart Fail Clin; 2006 Apr; 2(2):205-14. PubMed ID: 17386890
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of cardiac magnetic resonance (CMR) in the diagnosis of cardiomyopathy: A systematic review.
    Mayala HA; Bakari KH; Zhaohui W
    Malawi Med J; 2018 Dec; 30(4):291-295. PubMed ID: 31798809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undetermined stroke genesis and hidden cardiomyopathies determined by cardiac magnetic resonance.
    Fonseca AC; Marto JP; Pimenta D; Guimarães T; Alves PN; Inácio N; Viana-Baptista M; Pinho E Melo T; Pinto FJ; Ferro JM; Almeida AG
    Neurology; 2020 Jan; 94(1):e107-e113. PubMed ID: 31792090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.